Last reviewed · How we verify
NCT05956873: REVAR-TAAA
Endovascular Aortic Repair of Free and Contained Ruptured Thoraco-Abdominal Aortic Aneurysm
trial testing REVAR in Thoracoabdominal Aortic Aneurysm in 100 participants. Completed in 1 July 2023.
1 January 2023
Quick facts
| Lead sponsor | University of Bologna |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 January 2015 |
| Primary completion | 1 January 2023 |
| Estimated completion | 1 July 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- REVAR
Conditions studied
- Thoracoabdominal Aortic Aneurysm — all drugs for Thoracoabdominal Aortic Aneurysm →
- Ruptured Thoracic Aneurysm — all drugs for Ruptured Thoracic Aneurysm →
- Ruptured Aortic Aneurysm — all drugs for Ruptured Aortic Aneurysm →
- Thoracoabdominal Aortic Aneurysm, Ruptured — all drugs for Thoracoabdominal Aortic Aneurysm, Ruptured →
Sponsor
University of Bologna
Who can join
18 and older, any sex, with Thoracoabdominal Aortic Aneurysm or Ruptured Thoracic Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ruptured thoracoabdominal aortic aneurysm (TAAA) represents an emergency medical challenge that needs to be treated promptly. Over the past years different endovascular techniques have emerged such as fenestrated or branched endovascular aortic repair (FB-EVAR). However, FB-EVAR is a technique that uses a custom-made device which needs to be manufactured and this process take months, therefore, it could not be used in urgent settings. Off-the-shelf graft stents are pre-made graft stents, which can be used in urgent cases. A retrospective, multicenter cohort study was planned to include patients who underwent endovascular procedures between January 2015 and January 2022 (85 months) to evaluate the technical and survival outcomes of the use of off-the-shelf stent graft, physician-modified endograft and parallel graft technique in endovascular aortic repair of free and contained ruptured TAAA. Data will be collected anonymously and retrospectively, including patient demographics, risk factors, diagnosis and anatomical details, procedure details and post-operative outcomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Endovascular Repair of 100 Urgent and Emergent Free or Contained Thoracoabdominal Aortic Aneurysms Ruptures. An International Multicenter Trans-Atlantic Experience.
Spath P, Tsilimparis N, Gallitto E, Becker D, et al · · 2025 · cited 8× · PMID 38323417 · DOI 10.1097/sla.0000000000006231
Verify or expand the search:
- PubMed search for NCT05956873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thoracoabdominal Aortic Aneurysm
Currently open trials in the same condition.
- NCT07147569 — TAMBE Japan Post-Marketing Surveillance · recruiting
- NCT06478576 — Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm · NA · recruiting
- NCT05758844 — The Safe-line Technique as Additional Attempt to Mitigate Spinal Cord Ischemia After Endovascular Exclusion of TAAA · recruiting
- NCT06969729 — Evaluation of Clinical Efficacy and Safety of Aortal Stent-Graft Created Using 3D Printing Technology · NA · recruiting
- NCT07141251 — Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02) · Phase 1 · recruiting
Other University of Bologna trials
Trials by the same sponsor.
- NCT07431047 — Fast-Track Protocol for Endovascular Aneurysm Repair (EVAR) of Infrarenal Abdominal Aortic Aneurysms · not yet recruiting
- NCT07295197 — Oral Indicators for ED Screening · recruiting
- NCT07198789 — Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid · NA · not yet recruiting
- NCT07127796 — Non-inferiority RCT on Fish Waste-Derived vs. Synthetic Vitamin D Supplementation in Healthy Adults With Suboptimal Vita · NA · not yet recruiting
- NCT07041060 — Evaluation of the Efficacy and Safety of Eolo in Patients With NERD · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05956873 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Bologna
- Last refreshed: 24 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05956873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing